Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1997 Apr;52(Suppl 2):S92–S101. doi: 10.1136/thx.52.2008.s92

Selecting and using nebuliser equipment

A H Kendrick, E C Smith, R S Wilson
PMCID: PMC1765870  PMID: 9155861

Full Text

The Full Text of this article is available as a PDF (123.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brain J. D., Valberg P. A. Deposition of aerosol in the respiratory tract. Am Rev Respir Dis. 1979 Dec;120(6):1325–1373. doi: 10.1164/arrd.1979.120.6.1325. [DOI] [PubMed] [Google Scholar]
  2. Cipolla D., Gonda I., Shire S. J. Characterization of aerosols of human recombinant deoxyribonuclease I (rhDNase) generated by jet nebulizers. Pharm Res. 1994 Apr;11(4):491–498. doi: 10.1023/a:1018998028490. [DOI] [PubMed] [Google Scholar]
  3. Clay M. M., Pavia D., Newman S. P., Clarke S. W. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax. 1983 Oct;38(10):755–759. doi: 10.1136/thx.38.10.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clay M. M., Pavia D., Newman S. P., Lennard-Jones T., Clarke S. W. Assessment of jet nebulisers for lung aerosol therapy. Lancet. 1983 Sep 10;2(8350):592–594. doi: 10.1016/s0140-6736(83)90679-7. [DOI] [PubMed] [Google Scholar]
  5. Dennis J. H., Stenton S. C., Beach J. R., Avery A. J., Walters E. H., Hendrick D. J. Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output. Thorax. 1990 Oct;45(10):728–732. doi: 10.1136/thx.45.10.728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Douglas J. G., Leslie M. J., Crompton G. K., Grant I. W. Is the flow rate used to drive a jet nebuliser clinically important? Br Med J (Clin Res Ed) 1985 Jan 5;290(6461):29–29. doi: 10.1136/bmj.290.6461.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Everard M. L., Clark A. R., Milner A. D. Drug delivery from jet nebulisers. Arch Dis Child. 1992 May;67(5):586–591. doi: 10.1136/adc.67.5.586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hung J. C., Hambleton G., Super M. Jet nebulising systems for recombinant human DNase I. Arch Dis Child. 1994 Dec;71(6):558–559. doi: 10.1136/adc.71.6.558-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hurley P. K., Smye S. W., Cunliffe H. Assessment of antibiotic aerosol generation using commercial jet nebulizers. J Aerosol Med. 1994 Fall;7(3):217–228. doi: 10.1089/jam.1994.7.217. [DOI] [PubMed] [Google Scholar]
  10. Kendrick A. H., Smith E. C., Denyer J. Nebulizers--fill volume, residual volume and matching of nebulizer to compressor. Respir Med. 1995 Mar;89(3):157–159. doi: 10.1016/0954-6111(95)90241-4. [DOI] [PubMed] [Google Scholar]
  11. Loffert D. T., Ikle D., Nelson H. S. A comparison of commercial jet nebulizers. Chest. 1994 Dec;106(6):1788–1792. doi: 10.1378/chest.106.6.1788. [DOI] [PubMed] [Google Scholar]
  12. Malone R. A., Hollie M. C., Glynn-Barnhart A., Nelson H. S. Optimal duration of nebulized albuterol therapy. Chest. 1993 Oct;104(4):1114–1118. doi: 10.1378/chest.104.4.1114. [DOI] [PubMed] [Google Scholar]
  13. Mercer T. T. Production and characterization of aerosols. Arch Intern Med. 1973 Jan;131(1):39–50. [PubMed] [Google Scholar]
  14. Newman S. P., Pellow P. G., Clay M. M., Clarke S. W. Evaluation of jet nebulisers for use with gentamicin solution. Thorax. 1985 Sep;40(9):671–676. doi: 10.1136/thx.40.9.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Newnham D. M., Lipworth B. J. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream"). Thorax. 1994 Aug;49(8):762–770. doi: 10.1136/thx.49.8.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. O'Callaghan C. How to get drugs into the respiratory tract. Arch Dis Child. 1993 Apr;68(4):441–443. doi: 10.1136/adc.68.4.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pang J., Chan H. S., Sung J. Y. Prevalence of asthma in patients with bronchiectasis in Hong Kong. Eur Respir J. 1993 Jan;6(1):148–149. [PubMed] [Google Scholar]
  18. Rees P. J., Clark T. J., Morén F. The importance of particle size in response to inhaled bronchodilators. Eur J Respir Dis Suppl. 1982;119:73–78. [PubMed] [Google Scholar]
  19. Ruffin R. E., Wolff R. K., Dolovich M. B., Rossman C. M., Fitzgerald J. D., Newhouse M. T. Aerosol therapy with Sch 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjects. Chest. 1978 Apr;73(4):501–506. doi: 10.1378/chest.73.4.501. [DOI] [PubMed] [Google Scholar]
  20. Samaniego F., Newman L. S. Migratory anisocoria--a novel clinical entity. Am Rev Respir Dis. 1986 Oct;134(4):844–844. doi: 10.1164/arrd.1986.134.4.844. [DOI] [PubMed] [Google Scholar]
  21. Shah P., Dhurjon L., Metcalfe T., Gibson J. M. Acute angle closure glaucoma associated with nebulised ipratropium bromide and salbutamol. BMJ. 1992 Jan 4;304(6818):40–41. doi: 10.1136/bmj.304.6818.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Smith E. C., Denyer J., Kendrick A. H. Comparison of twenty three nebulizer/compressor combinations for domiciliary use. Eur Respir J. 1995 Jul;8(7):1214–1221. doi: 10.1183/09031936.95.08071214. [DOI] [PubMed] [Google Scholar]
  23. Smye S. W., Shaw A., Norwood H. M., Littlewood J. M. Some factors influencing the efficiency of a jet nebuliser system. Clin Phys Physiol Meas. 1990 May;11(2):167–175. doi: 10.1088/0143-0815/11/2/007. [DOI] [PubMed] [Google Scholar]
  24. Swift D. L. Aerosols and humidity therapy. Generation and respiratory deposition of therapeutic aerosols. Am Rev Respir Dis. 1980 Nov;122(5 Pt 2):71–77. doi: 10.1164/arrd.1980.122.5.71. [DOI] [PubMed] [Google Scholar]
  25. Thomas S. H., O'Doherty M. J., Page C. J., Nunan T. O., Bateman N. T. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers. Eur Respir J. 1991 May;4(5):616–622. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES